Rowe JM - Search Results

1

Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia.

Rowe JM, Lichtman MA. Rowe JM, et al. Blood. 1984 May;63(5):1230-4. Blood. 1984. PMID: 6585236 Free article.

2

Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations.

Lichtman MA, Rowe JM. Lichtman MA, et al. Among authors: rowe jm. Blood. 1982 Aug;60(2):279-83. Blood. 1982. PMID: 7046844 Free article. Review.

3

Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

Liesveld JL, Rowe JM, Lichtman MA. Liesveld JL, et al. Among authors: rowe jm. Blood. 1987 Mar;69(3):820-6. Blood. 1987. PMID: 3814817 Free article.

4

Attachment of particle-bound IgG and complement to human neutrophils.

Lawrence WD, Packman CH, Rowe JM, Lichtman MA. Lawrence WD, et al. Among authors: rowe jm. Blood. 1981 Oct;58(4):772-81. Blood. 1981. PMID: 7272507 Free article.

5

Hyperleukocytic leukaemia: rheological and clinical features and management.

Lichtman MA, Heal J, Rowe JM. Lichtman MA, et al. Among authors: rowe jm. Baillieres Clin Haematol. 1987 Sep;1(3):725-46. doi: 10.1016/s0950-3536(87)80022-7. Baillieres Clin Haematol. 1987. PMID: 3327563 Review. No abstract available.

6

Hyperleukocytosis, leukostasis and leukapheresis: practice management.

Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Ganzel C, et al. Among authors: rowe jm. Blood Rev. 2012 May;26(3):117-22. doi: 10.1016/j.blre.2012.01.003. Epub 2012 Feb 23. Blood Rev. 2012. PMID: 22364832 Review.

7

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM. Tallman MS, et al. Among authors: rowe jm. Blood. 2000 Aug 15;96(4):1254-8. Blood. 2000. PMID: 10942365 Free article.

8

Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.

Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Blood. 1988 Apr;71(4):992-6. Blood. 1988. PMID: 3162695 Free article.

9

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

10

How I treat acute myeloid leukemia.

Rowe JM, Tallman MS. Rowe JM, et al. Blood. 2010 Oct 28;116(17):3147-56. doi: 10.1182/blood-2010-05-260117. Epub 2010 Jun 17. Blood. 2010. PMID: 20558611 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page